
The tragedy, or opportunity — depending on how you choose to look at it — is that if kala azar is a neglected disease, for some reason, this is a ‘neglected drug’. Who pays the price for the health system ignoring this drug?
The writer is a lawyer and Mumbai-based management consultant kavitakhanna108@gmail.com